Analyst Ratings for Aquestive Therapeutics (AQST)

AQST Rating Summary

AQST Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AQST
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $18.50 (+357.9%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/7/2021 RBC Capital Daniel Busb New Coverage Outperform
(N/A)
7.00
(N/A)
5.21
(4.04)
-22.46% Details
4/22/2019 H.C. Wainwright
» Updated 12/2/2019
Raghuram Selvaraju New Coverage Buy
(N/A)
14.00
(12.00)
6.29
(4.04)
-35.77% Details
Like AQST Ratings? Also take a look at FRLN, SCYX, NRX, DCTH

AQST Ratings News